Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7

Since the approval of imatinib in 2001, kinase inhibitors have revolutionized cancer therapies. Inside this family of phosphotransferases, casein kinase 2 (CK2) is of great interest and numerous scaffolds have been investigated to design CK2 inhibitors. Recently, functionalized indeno[1,2-b]indoles...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmaceuticals (Basel)
Egile Nagusiak: Nacereddine, Abdelhamid, Bollacke, Andre, Róka, Eszter, Marminon, Christelle, Bouaziz, Zouhair, Fenyvesi, Ferenc, Bácskay, Ildikó Katalin, Jose, Joachim, Perret, Florent, Le Borgne, Marc
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874706/
https://ncbi.nlm.nih.gov/pubmed/29373552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph11010010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak